Simran Farms Allots Shares to Raise Capital from Warrants

AGRICULTURE
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Simran Farms Allots Shares to Raise Capital from Warrants
Overview

Simran Farms Limited's board approved allotting 10,18,300 shares from warrant conversion. This capital infusion aims to support growth, pending shareholder approval for a related resolution.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Simran Farms Limited is set to increase its equity capital after its board approved the allotment of 10,18,300 equity shares. The shares are priced at ₹155 each, issued upon the conversion of warrants.

Board Approves Share Allotment

On March 30, 2026, the Board of Directors at Simran Farms Limited approved the allotment of 10,18,300 equity shares. Warrant holders will pay the remaining 75% of the subscription amount, which is ₹116.25 per share, on top of the initial payment, bringing the total issue price to ₹155 per share. The Board also approved issuing a notice for a postal ballot to obtain shareholder consent on a proposed resolution.

Capital Infusion and Strategic Steps

This allotment represents a significant potential capital infusion for Simran Farms. Such funding can bolster the company's financial position, providing resources for its operations and expansion projects. The need for shareholder approval through a postal ballot indicates a formal procedural step towards completing these corporate actions.

Background on Capital Strategy and Financials

Simran Farms, an integrated poultry business based in Indore, utilizes a contract farming model and produces its own feed. This allotment follows a previous move in August 2024 when the company approved raising about ₹15.7 crore via convertible warrants, signaling an ongoing capital-raising strategy. The company has faced financial challenges, reporting a net loss for the quarter ending December 2023 and a Debt-to-Equity ratio of 145.14% as of March 2025. Despite these pressures, Simran Farms has also outlined plans to expand its farm capacity.

Key Immediate Impacts

Upon successful payment by warrant holders, the company's total equity share capital will rise. This infusion of funds is contingent on the warrant holders completing their payments.

Key Risks to Monitor

A primary risk is that warrant holders might not pay the remaining ₹116.25 per share, which would prevent the capital infusion. Additionally, the company's existing high Debt-to-Equity ratio of 145.14% (as of March 2025) means that successful and timely capital raises are critical for managing its leveraged financial position.

Industry Context

Simran Farms operates within the poultry sector, which includes listed companies such as Venky's (India) Limited. Venky's has shown mixed financial results, with both losses and turnarounds reported recently. Other agribusiness players like Godrej Agrovet also operate in the wider sector.

What to Watch For Next

Investors will be watching for the results of the postal ballot and shareholder resolution. Confirmation that all warrant holders have submitted the remaining payment will be key. The formal listing of the newly allotted shares will also be an important development. Furthermore, observing how Simran Farms utilizes the new capital to enhance its financial standing and fuel expansion plans will be crucial.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.